These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 692838

  • 1. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ, Saxena B, Foley P, Grof P.
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
    Kane J, Quitkin F, Rifkin A, Klein DF.
    Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
    [Abstract] [Full Text] [Related]

  • 3. A comparative trail of fluphenazine decanoate and flupenthixol decanoate.
    Haslam MT, Bromham BM, Schiff AA.
    Acta Psychiatr Scand; 1975 Feb; 51(2):92-100. PubMed ID: 1091124
    [Abstract] [Full Text] [Related]

  • 4. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB, Lewine RR, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C.
    Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
    [Abstract] [Full Text] [Related]

  • 5. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ, Young MA, Charles J, Elgart B, Von Greiff H, Simpson GM.
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [Abstract] [Full Text] [Related]

  • 6. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G, Annable L, Ross-Chouinard A.
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA.
    Pharmatherapeutica; 1983 Mar; 3(5):289-93. PubMed ID: 6133287
    [Abstract] [Full Text] [Related]

  • 8. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [Abstract] [Full Text] [Related]

  • 9. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R, Bannerjee A, Ghosh N.
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [Abstract] [Full Text] [Related]

  • 11. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Oct; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 12. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S, Cookson JC, Silverstone T.
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [Abstract] [Full Text] [Related]

  • 13. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M, Alvarez C, Herlin S.
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [Abstract] [Full Text] [Related]

  • 14. The long-term use of high doses of fluphenazine enanthate and fluphenazine decanoate.
    Verhaegen JJ.
    Compr Psychiatry; 1975 Oct; 16(4):357-62. PubMed ID: 1157479
    [No Abstract] [Full Text] [Related]

  • 15. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC, Kennedy NM, Gribbon D.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
    Johnson DA, Malik NA.
    Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
    [Abstract] [Full Text] [Related]

  • 17. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B.
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [Abstract] [Full Text] [Related]

  • 18. Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
    Frangos H, Zissis NP, Leontopoulos I, Diamantas N, Tsitouridis S, Gavriil I, Tsolis K.
    Acta Psychiatr Scand; 1978 May; 57(5):436-46. PubMed ID: 354331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.